Baroda BNP Paribas Value Fund
(An open ended equity scheme following a value investment strategy)
Baroda BNP Paribas Value Fund
(An open ended equity scheme following a value investment strategy)
May 2025

May 2025


Investment Objective

The investment objective of the scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments by following a value investment strategy. However, there can be no assurance that the investment objectives of the Scheme will be realized. The Scheme does not guarantee/indicate any returns.

NAV Details (As on May 30, 2025)
Regular Plan - IDCW Option : ₹12.5548
Regular Plan - Growth Option : ₹13.7698
Direct Plan - IDCW Option : ₹12.9099
Direct Plan - Growth Option : ₹14.1583
Benchmark Index (Tier 1)

Nifty 500 TRI

Date of Allotment

June 7, 2023

Fund Manager
Fund Manager Managing fund since Experience
Mr. Shiv Chanani 07-Jun-23 21 years
Mr. Himanshu Singh 21-Oct-24 10 years
Load Structure

Exit Load: • If units of the Scheme are redeemed or switched out up to 10% of the units (the limit) within 1 year from the date of allotment - Nil. • If units of the scheme are redeemed or switched out in excess of the limit within 1 year from the date of allotment - 1% of the applicable NAV. • If units of scheme are redeemed or switched out after 1 year from the date of allotment - Nil.
For detailed load structure please refer Scheme Information Document.


Lumpsum Details

Minimum Amount: Lumpsum investment:
₹ 5,000 and in multiples of ₹ 1 thereafter.
Minimum Additional Application Amount:₹ 1,000 and in multiples of ₹ 1 thereafter.


Monthly AAUM## As on May 30, 2025 : ₹ 1,316.76 Crores
AUM## As on May 30, 2025 : ₹ 1,319.04 Crores

## including inter-scheme Investments, if any, by other schemes of Baroda BNP Paribas Mutual Fund, as may be applicable

EQUITY HOLDINGS % of Net Assets
Banks 17.36%
HDFC Bank Limited 6.64%
ICICI Bank Limited 5.92%
Kotak Mahindra Bank Limited 3.93%
Canara Bank 0.87%
Pharmaceuticals & Biotechnology 11.56%
Divi's Laboratories Limited 2.51%
Alkem Laboratories Limited 2.32%
Sun Pharmaceutical Industries Limited 1.53%
Torrent Pharmaceuticals Limited 1.20%
Sanofi India Limited 1.16%
Cipla Limited 1.11%
Sanofi Consumer Healthcare India Limited 0.92%
Zydus Lifesciences Limited 0.81%
IT - Software 9.57%
Infosys Limited 5.63%
Tata Consultancy Services Limited 3.94%
Petroleum Products 7.26%
Reliance Industries Limited 5.39%
Hindustan Petroleum Corporation Limited 1.87%
Power 6.29%
NTPC Limited 2.78%
SJVN Limited 1.97%
Power Grid Corporation of India Limited 1.54%
Gas 5.59%
Mahanagar Gas Limited 2.71%
GAIL (India) Limited 1.01%
Petronet LNG Limited 0.99%
Gujarat State Petronet Limited 0.88%
Electrical Equipment 4.60%
Bharat Heavy Electricals Limited 2.36%
GE Vernova T&D India Limited 2.24%
Automobiles 4.02%
TVS Motor Company Limited 1.26%
Eicher Motors Limited 1.01%
Maruti Suzuki India Limited 0.93%
Hero MotoCorp Limited 0.82%
Finance 3.85%
Power Finance Corporation Limited 1.95%
Mas Financial Services Limited 1.90%
Auto Components 3.54%
Jtekt India Limited 1.24%
Exide Industries Limited 1.17%
Sundaram Clayton Limited 1.13%
Insurance 3.23%
ICICI Prudential Life Insurance Company Limited 1.76%
HDFC Life Insurance Company Limited 1.47%
Consumable Fuels 2.86%
Coal India Limited 2.86%
Construction 2.79%
Larsen & Toubro Limited 2.79%
Cement & Cement Products 2.22%
UltraTech Cement Limited 1.44%
The India Cements Limited 0.78%
Consumer Durables 2.13%
Crompton Greaves Consumer Electricals Limited 1.20%
Blue Star Limited 0.93%
Aerospace & Defense 1.75%
Bharat Electronics Limited 1.75%
Oil 1.62%
Oil India Limited 1.62%
Agricultural Food & other Products 1.11%
AWL Agri Business Limited 1.11%
Beverages 0.90%
Varun Beverages Limited 0.90%
LESS THAN 0.75% EXPOSURE 2.48%
TOTAL EQUITY HOLDING 94.73%
FIXED INCOME HOLDINGS Rating % of Net Assets
Treasury Bill 1.48%
364 Days Tbill (MD 10/07/2025) SOV 0.75%
364 Days Tbill (MD 04/09/2025) SOV 0.37%
364 Days Tbill (MD 16/04/2026) SOV 0.36%
Total Fixed Income Holdings 1.48%
TREPS, Cash & Other Net Current Assets 3.79%
GRAND TOTAL 100.00%

Investment in Top 10 scrips constitutes 42.59% of the portfolio


For SIP Performance please click here

For Scheme Performance please click here


Pursuant to distribution under Income Distribution cum Capital Withdrawal (‘IDCW’) option, NAV of the IDCW option of the scheme(s) would fall to the extent of payout and statutory levy (if applicable). The amounts under IDCW options can be distributed out of investors capital (Equalization Reserve), which is part of sale price that represents realized gains. Past performance may or may not be sustained in future. The above stated distribution rate per unit is net distribution rate after deducting applicable taxes. The above distribution rates are on face value of ₹ 10 per unit.

TER - Regular Plan (%) 2.18%
TER - Direct Plan (%) 1.08%
Portfolio Turnover Ratio 0.73

*The information contained in this report has been obtained from sources considered to be authentic and reliable. This quantitative data does not purport to be an offer for purchase and sale of mutual fund units.
The risk free rate of return considered for calculation of Sharpe ratio is 5.86%, as per 1 day MIBOR rate on the last business day of the month

No of Stocks 51
Portfolio RoE (%) 16.94
EPS Growth (%) 21.35

This product is suitable for investors who are seeking*:

➤ Capital appreciation over long term.
➤ Investment predominantly in a portfolio of equity and equity related securities by following a value investment strategy

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.

Scheme Riskometer^^
Investors understand that their principal will be at Very High risk


Benchmark (Tier 1) Riskometer^
Benchmark riskometer is at Very High risk


^^Riskometer For Scheme: basis it’s portfolio, ^Riskometer For Benchmark (Nifty 500 TRI): basis it’s constituents; As on May 30, 2025

For complete portfolio, kindly refer the website https://www.barodabnpparibasmf.in/
Mutual Fund investments are subject to market risks, read all scheme related documents carefully.